These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Can we face the challenge of expanding use of intravenous immunoglobulin in neurology? Elovaara I; Hietaharju A Acta Neurol Scand; 2010 Nov; 122(5):309-15. PubMed ID: 20085560 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of various intravenous immunoglobulin therapy protocols in autoimmune and chronic inflammatory disorders. Gürcan HM; Ahmed AR Ann Pharmacother; 2007 May; 41(5):812-23. PubMed ID: 17440006 [TBL] [Abstract][Full Text] [Related]
5. [Use of high dose intravenous immunoglobulin in neurologic disease]. Korsak J; Zaleska B; Orłowska E; Kotowicz J Pol Merkur Lekarski; 2005 Jul; 19(109):98-101. PubMed ID: 16194039 [TBL] [Abstract][Full Text] [Related]
6. Posterior reversible encephalopathy syndrome associated with IVIG in a patient with Guillain-Barré syndrome. Koichihara R; Hamano S; Yamashita S; Tanaka M Pediatr Neurol; 2008 Aug; 39(2):123-5. PubMed ID: 18639758 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin for concurrent Guillain-Barré and immune thrombocytopenic purpura. Zeidman LA; Fahey CD; Grinblatt DL; Harsanyi K Pediatr Neurol; 2006 Jan; 34(1):60-2. PubMed ID: 16376282 [TBL] [Abstract][Full Text] [Related]
8. [Immunotherapy of intravenous immunoglobulin preparations in neurologic diseases]. Lewańska M; Selmaj K Postepy Hig Med Dosw; 2002; 56 Suppl():69-83. PubMed ID: 12661417 [TBL] [Abstract][Full Text] [Related]
9. [The use of intravenous immunglobulin in the treatment of autoimmune neuromuscular diseases]. Molnár MJ Ideggyogy Sz; 2006 Mar; 59(3-4):98-106. PubMed ID: 16634454 [TBL] [Abstract][Full Text] [Related]
10. Guidelines for the use of intravenous immunoglobulin in the treatment of neurologic diseases. Bascić-Kes V; Kes P; Zavoreo I; Lisak M; Zadro L; Corić L; Demarin V; Acta Clin Croat; 2012 Dec; 51(4):673-83. PubMed ID: 23540178 [TBL] [Abstract][Full Text] [Related]
12. Intravenous immunoglobulin in autoimmune neuromuscular diseases. Dalakas MC JAMA; 2004 May; 291(19):2367-75. PubMed ID: 15150209 [TBL] [Abstract][Full Text] [Related]
13. [Use of i.v. immunoglobulins in neurology. Evidence-based consensus]. Stangel M; Gold R Nervenarzt; 2004 Aug; 75(8):801-15. PubMed ID: 15224177 [TBL] [Abstract][Full Text] [Related]
14. The use of intravenous immunoglobulin in the treatment of autoimmune neuromuscular diseases: evidence-based indications and safety profile. Dalakas MC Pharmacol Ther; 2004 Jun; 102(3):177-93. PubMed ID: 15246245 [TBL] [Abstract][Full Text] [Related]
15. [Use of intravenous immunoglobulin in neurological disorders]. Steck AJ Rev Med Suisse; 2005 Apr; 1(17):1167-70. PubMed ID: 15941089 [TBL] [Abstract][Full Text] [Related]
16. Intravenous immunoglobulin: striving for appropriate use. Kumar A; Teuber SS; Gershwin ME Int Arch Allergy Immunol; 2006; 140(3):185-98. PubMed ID: 16682800 [TBL] [Abstract][Full Text] [Related]
17. Intravenous immunoglobulin in autoimmune and inflammatory diseases: more than mere transfer of antibodies. Sibéril S; Elluru S; Negi VS; Ephrem A; Misra N; Delignat S; Bayary J; Lacroix-Desmazes S; Kazatchkine MD; Kaveri SV Transfus Apher Sci; 2007 Aug; 37(1):103-7. PubMed ID: 17765663 [TBL] [Abstract][Full Text] [Related]
18. [Immunoglobulins and physiopathology: actual indications]. Mouthon L; Guilpain P Rev Med Interne; 2007 May; 28 Spec No. 1():11-7. PubMed ID: 17768833 [TBL] [Abstract][Full Text] [Related]